"0074-2600-60" National Drug Code (NDC)

NDC Code	0074-2600-60
Package Description	1 PACKET in 1 CARTON (0074-2600-60) > 60 PELLET in 1 PACKET
Product NDC	0074-2600
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Mavyret
Non-Proprietary Name	Glecaprevir And Pibrentasvir
Dosage Form	PELLET
Usage	ORAL
Start Marketing Date	20210610
Marketing Category Name	NDA
Application Number	NDA215110
Manufacturer	AbbVie Inc.
Substance Name	PIBRENTASVIR; GLECAPREVIR
Strength	20; 50
Strength Unit	mg/1; mg/1
Pharmacy Classes	Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],UGT1A1 Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],HCV NS3/4A Protease Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],UGT1A1 Inhibitors [MoA]